We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Achieve Life Sciences initiates cytisine clinical development programme Cytisine is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe for more than 15 years.
Achieve Life Sciences announced the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for cytisine, an established smoking cessation treatment that has been approved and marketed in Central and Eastern Eur